APX-3330 is under clinical development by Opus Genetics and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR). According to GlobalData, Phase II drugs for Non-Proliferative ...

Introduction: Diabetic retinopathy (DR) has long been recognized as ... Specifically, MESSIDOR includes 546 images classified as DR0 (normal), 153 images as DR1 (mild), 247 images as DR2 (moderate), ...